This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignee: Dexcom, Inc.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Innovations by Enrique Campos-Náñez
Introduction
Enrique Campos-Náñez is a notable inventor based in San Diego, CA. He has made significant contributions to the field of diabetes management through his innovative patents. With a total of 4 patents, his work focuses on improving the estimation of exogenous pharmacons in the body.
Latest Patents
One of his latest patents is the Dynamic Equivalent On Board Estimator. This invention provides an adaptive on-board estimation of exogenous pharmacons responsive to transient physiological effects. It dynamically estimates the equivalent amount of an exogenous pharmacon on board, such as insulin and/or carbohydrates, based on predictions of glucose time-series data. These estimated values, such as insulin on board (IOB), are particularly useful for diabetes management software, including decision support and artificial pancreas algorithms.
Career Highlights
Enrique Campos-Náñez is currently associated with Dexcom, Inc., a company known for its advancements in continuous glucose monitoring technology. His work at Dexcom has been instrumental in developing solutions that enhance diabetes management for patients.
Collaborations
Enrique collaborates with Stephen D Patek, contributing to the innovative environment at Dexcom, Inc. Their combined expertise fosters advancements in diabetes technology.
Conclusion
Enrique Campos-Náñez is a prominent inventor whose work in diabetes management through innovative patents has made a significant impact. His contributions continue to shape the future of healthcare technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile